Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
Nov 25, 08:30 PM
Share
Subscribe
In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes out a $1.5 billion loan to support its long-term growth plan, and Medicare moves closer to releasing negotiated prices for 15 widely used, high-cost medicines.